AngioDynamics Announces CEO Transition
AngioDynamics (ANGO) announced that Eric Honroth will become president and chief executive officer, effective November 2, 2026. He will also join the company’s board of directors at that time. Jim Clemmer is set to retire from his role as CEO and step down from the board on the same date but will remain with the company during a transition period. The leadership change marks a strategic shift for AngioDynamics, which operates in the medical device sector. Honroth brings extensive experience in healthcare management and has previously held executive roles at other medtech firms. The announcement aims to ensure continuity as Clemmer transitions out of his role after years of leading the company. The market reaction is expected to be neutral or cautiously positive depending on investor confidence in leadership changes within the medical device industry.
Tickers: $ANGO